Inventor
SOWELL C GREGORY
US33 patents
⚠️ This page may combine multiple inventors who share the name “SOWELL C GREGORY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CORIXA CORP
11 patentsUS6303347B1Oct 16, 2001
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
CORIXA CORP277 citations99
US6764840B2Jul 20, 2004
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
CORIXA CORP128 citations98
US6355257B1Mar 12, 2002
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
CORIXA CORP119 citations98
US6525028B1Feb 25, 2003
Immunoeffector compounds
CORIXA CORP186 citations97
US7129219B2Oct 31, 2006
Immunoeffector compounds
CORIXA CORP59 citations96
US7541020B2Jun 2, 2009
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
CORIXA CORP11 citations84
US7063967B2Jun 20, 2006
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
CORIXA CORP17 citations84
US7288640B2Oct 30, 2007
Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
CORIXA CORP15 citations83
US6399590B2Jun 4, 2002
Phosphoglycolipid and methods for its use
CORIXA CORP5 citations72
US7232900B2Jun 19, 2007
Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor
CORIXA CORP6 citations61
US7501399B2Mar 10, 2009
Immunoeffector compounds
CORIXA CORP4 citations57
ICOS CORP
7 patentsUS6949535B2Sep 27, 2005
Inhibitors of human phosphatidyl-inositol 3-kinase delta
ICOS CORP172 citations99
US6667300B2Dec 23, 2003
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP174 citations99
US6518277B1Feb 11, 2003
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP272 citations99
US9487772B2Nov 8, 2016
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP19 citations96
US10010550B2Jul 3, 2018
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP11 citations92
US10695349B2Jun 30, 2020
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP2 citations84
US10398695B2Sep 3, 2019
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP5 citations84
SADHU CHANCHAL
5 patentsUS8637533B2Jan 28, 2014
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL48 citations97
US8623881B2Jan 7, 2014
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL41 citations97
US8492389B2Jul 23, 2013
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL47 citations97
US8138195B2Mar 20, 2012
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL64 citations96
US8653077B2Feb 18, 2014
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL39 citations95
EXELIXIS INC
4 patentsUS10239858B2Mar 26, 2019
Process for making compounds for use in the treatment of cancer
EXELIXIS INC3 citations71
US9771347B2Sep 26, 2017
Process for making compounds for use in the treatment of cancer
EXELIXIS INC3 citations71
US11414396B2Aug 16, 2022
Process for making compounds for use in the treatment of cancer
EXELIXIS INC0 citations61
US10793541B2Oct 6, 2020
Process for making compounds for use in the treatment of cancer
EXELIXIS INC0 citations50
ARRAY BIOPHARMA INC
3 patentsUS9790190B2Oct 17, 2017
Process for making hydroxylated cyclopentylpyrimidine compounds
ARRAY BIOPHARMA INC7 citations83
US9676730B2Jun 13, 2017
Process for making hydroxylated cyclopentylpyrimidine compounds
ARRAY BIOPHARMA INC9 citations83
US9416110B2Aug 16, 2016
Process for making hydroxylated cyclopentylpyrimidine compounds
ARRAY BIOPHARMA INC10 citations83